Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Chief Tech/Sci/R&D Officer - 17/07/2009
Director of Finance/CFO 60 01/07/2022
Director TitleAgeSince
Director/Board Member 58 09/07/2020
Chairman 68 09/12/2021
Director/Board Member 78 01/09/2004
Date Insider Type Main position Quantity % Market Cap. Importance
09/07/20 Tender

Chief Executive Officer

29,206 0.1196%
09/07/20 Tender

Chief Financial Officer

500 0.0020% -
09/07/20 Tender

Director

1,02,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 14.13L
+1.56%+2.41%-14.82%+14.19% 18TCr
-6.38%-4.98%-20.90%+11.15% 11TCr
-0.59%+1.18%+6.12%+37.97% 12TCr
+3.42%+1.71%-42.32%+9.52% 9.46TCr
+0.09%-0.05%-3.04%+78.44% 6.31TCr
-0.46%+0.42%+8.19%+82.97% 5.57TCr
-0.23%-0.52%+10.31%-21.19% 5.39TCr
-4.30%-1.64%-12.30%+39.06% 4.34TCr
+0.58%+2.00%-1.07%-6.43% 3.47TCr
Average -0.63%+0.06%-7.76%+27.30% 8.44TCr
Weighted average by Cap. -0.49%+0.23%-10.66%+25.22%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-